|
Mr. Shaw is a Partner in Brown Rudnick's London office. He practices in Corporate Finance, advising technology companies and venture/development capital investors on their funding rounds, "buy and build" programs and exit strategies (including trade sales and IPOs). A science graduate of St. Andrews University, Mr. Shaw has also developed a core expertise in advising biotechnology and life science companies on their growth and corporate strategies and has experience advising on commercial and funding strategies, corporate governance issues and commercial negotiation.
Representative Matters
o Represented the selling shareholders on the €100 million buy-out of Moneybookers.
o Represented Index Ventures on its syndicated $18 million equity investment in a major Russian online retailer.
o Represented Mind Candy Limited on its "Delaware flip" and $12 million series A equity investment by Accel Partners (among others).
o Represented Merlin Biosciences in connection with a £6 million spin-out and equity investment by a leading UK-based biotech VC investor.
o Represented Apax Partners (and others) in connection with the auction sale of Ionix Pharmaceuticals to Vemalis Plc.
o Represented Crescendo Ventures and Bond Ventures in connection with a $9 million equity refinancing of a Bermuda-based media company with a UK operating subsidiary.
o Represented a Scottish biotechnology company with an estimated market cap of £25 million in connection with a proposed AIM listing.
o Advised on a £60 million acquisition of city-based property using a Jersey Property Unit Trust.
Publications
o Assisted the British Venture Capital Association (BVCA) in the model venture capital financing documents drafting project
o Author, "An Overview: Non-leveraged Investments" (an overview of venture capital investments in seed and series A investment rounds), published by Practical Law Company (PLC) online
Bar Admissions & Memberships
o Admitted, Scottish Solicitor | 